期刊文献+

PL-11血小板分析仪检测血小板计数及聚集功能的性能评价 被引量:9

Performance evaluation of PL-11 platelet analyzer in the detection of platelet count and platelet aggregation
下载PDF
导出
摘要 目的:探讨PL-11血小板分析仪在检测血小板数量及聚集功能方面的性能。方法按照美国临床实验室标准化协会( CLSI)制定的仪器性能验证标准及我国卫生行业标准 WS/T 406-2012《临床血液学检验常规项目分析质量要求》对PL-11血小板分析仪进行血小板计数及聚集功能的性能评价。采用PL-11血小板分析仪、LBY-NJ4血小板聚集仪及TEG-5000血栓弹力图仪检测健康人群血小板聚集率,分析各仪器检测结果间的相关性。结果 PL-11血小板分析仪的批内及日间精密度均<1/3总误差(7%);携带污染率为0.32%;在(4.12~1380.4)×109/L线性范围内回归方程斜率为1.03,R2=0.993;血小板计数结果与血小板参考方法的结果符合率为84%,均符合行业标准要求。分别采用PL-11血小板分析仪、LBY-NJ4血小板聚集仪及TEG-5000血栓弹力图仪检测79例2型糖尿病患者单服用氯匹格雷前、后血小板聚集率,3种仪器之间差异均无统计学意义( P>0.05),患者服药前、后血小板聚集率差异有统计学意义(P<0.01)。结论 PL-11血小板分析仪可为临床提供准确、可靠的血小板计数及聚集功能的检测结果。 Objective To investigate the performance of PL-11 platelet analyzer in the detection of platelet count and platelet aggregation.Methods According to the instrument performance verification standards in the Clinical and Laboratory Standards Institute ( CLSI) and the Health Industry Standard of the People′s Republic of China, WS/T 406-2012:the Quality Standard of Routine Tests in Clinical Hematology, the performance of PL-11 platelet analyzer in the detection of platelet count and platelet aggregation were evaluated.Platelet aggregation rate in healthy subjects was compared for correlation, which was detected by PL-11 platelet analyzer, LBY-NJ4 platelet tester and TEG-5000 thromboelastogram.Results The within-run and inter-day precisions of PL-11 platelet analyzer were〈1/3 of total error (7%), and the carry-over rate was 0.32%.In (4.12-1 380.4) ×109/L linear range, the regression equation slope was 1.03 (R2 =0.993).The coincidence rate for platelet count by PL-11 platelet analyzer with reference method was 84%.There was no statistical significance of platelet aggregation rate among PL-11 platelet analyzer, LBY-NJ4 platelet tester and TEG-5000 thromboelastogram in 79 patients with type 2 diabetes mellitus (P〉0.05).However, there was statistical significance in platelet aggregation rates before and after taking clopidogrel hydrogen(P〈0.01).Conclusions PL-11 platelet analyzer can provide accurate and reliable results for platelet count and aggregation.
出处 《检验医学》 CAS 2015年第9期926-930,共5页 Laboratory Medicine
关键词 血小板聚集 血小板分析仪 连续血小板计数 性能评价 Platelet aggregation Platelet analyzer Continuous platelet count Performance evaluation
  • 相关文献

参考文献10

  • 1FURIE B, FURIE BC. Mechanisms of thrombus formation[J]. N Engl J Med, 2008,359(9) : 938- 949.
  • 2Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantative measurement methods[ S]. EP5-A2, CLSI, 2004.
  • 3National Committee for Clinical Laboratory Standards. Preliminary evaluation of quantitative clinical laboratory methods[ S]. EP10-A2, NCCLS, 2002.
  • 4National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures : a statistical approach approved[S]. EP6-A, NCCLS, 2003.
  • 5STEINHUBL SR, MOLITERNO DJ. The role of the platelet in the pathogenesis of atherothrombosis [ J ]. Am J Cardiovasc Drugs, 2005, 5(6) : 399-408.
  • 6HAUBELT H, ANDERS C, HELLSTERN P. Can platelet function tests predict the clinical eiffacy of aspirin [ J ]. Semin Thromb Hemost, 2005, 31 (4) : 404-410.
  • 7HWANG SJ, JEONG YH, KIM IS, et al. The cytochrome 2C19 * 2 and * 3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective pereutaneous cornary intervention[J]. Thromb Res, 2011, 127 ( 1 ) : 23- 28.
  • 8梁茜,杨希立,张健瑜,杨光,崔金环,肖平.CYP2C19基因多态性与氯吡格雷治疗后心血管事件发生!关系的研究[J].实用医学杂志,2013,29(23):3883-3884. 被引量:10
  • 9李晶华,李智,王吉影,许闪闪.2型糖尿病患者血小板-白细胞聚集体和血小板活化指标的研究[J].中华检验医学杂志,2012,35(10):940-944. 被引量:6
  • 10乔蕊,张捷.抗血小板药物治疗监测的进展[J].检验医学,2013,28(5):442-447. 被引量:7

二级参考文献30

  • 1American Diabetes Association. Standaeds of Medical Care in Diabetes-2006. Diabetes Care, 2006,29: s4-s42.
  • 2Konstantopoulos K, Neelameghaon S, Burns AR, et al. Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-seleetin and beta 2-integrin. Circulation, 1998,98:873-882.
  • 3Elalamy I, Chakroun T, Gerotziafas GT, et al. Circulating platelet-leukocyte aggregates : a marker of microvascular injury in diabetic patients. Thromb Res, 2008,121:843-848.
  • 4Habazettl H, Hanusch P, Kupatt C. Effects of endothelium/ leukocytes/platelet interaction on myocardial ischemia-reperfusion injury. Z Kardiol,2000,89 : IX/92-95.
  • 5Hu H, Li N, Li L,et al. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost ,2004,2 : 58-64.
  • 6Sarma J, Laan CA, Alam S, et al. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation, 2002,105:2166-2171.
  • 7Tschoepe D. commentary on Genetic variation of the plateletsurface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia,2003,46: 984-989.
  • 8Irving PM, Macey MG, Shah U, et al. Formation of plateletleukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis ,2004,10:361-372.
  • 9Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy [ J]. Am J Cardiol, 2009, 103 (3Suppl) : 27A-34A.
  • 10Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity [ J ]. Eur HeartJ, 2006, 27(6) : 647-654.

共引文献19

同被引文献61

引证文献9

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部